Company
Liverpool
Every investor coverage indicates participated in a round University of Liverpool raised.
Companies University of Liverpool acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Michael Clague | Professor of Molecular and Cellular Physiology | Brandon Capital portfolio |
| Sylvie Urbé | Professor of Molecular and Cellular Physiology | Brandon Capital portfolio |
Stories naming University of Liverpool. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Defence tech firm Q-CTRL reports a first-at-sea trial navigating a vessel with no satellite positioning, using a quantum gravity sensor hardened by software, reaching nautical-mile accuracy and extending its navigation product line.
Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.